You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 23, 2024

Details for Patent: 5,219,554


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 5,219,554
Title: Hydrated biodegradable superparamagnetic metal oxides
Abstract:This invention relates to materials exhibiting certain magnetic and biological properties which make them uniquely suitable for use as magnetic resonance imaging (MRI) agents to enhance MR images of animal organs and tissues. More particularly, the invention relates to the in vivo use of biologically degradable and metabolizable superparamagnetic metal oxides as MR contrast agents. Depending on their preparation, these metal oxides are in the form of superparamagnetic particle dispersoids or superparamagnetic fluids where the suspending medium is a physiologically-acceptable carrier, and may be uncoated or surrounded by a polymeric coating to which biological molecules can be attached. These materials are administered to animals, including humans, by a variety of routes and the metal oxides therein collect in specific target organs to be imaged; in the case of coated particles, the biological molecules can be chosen to target specific organs or tissues. The biodistribution of the metal oxides in target organs or tissues results in a more detailed image of such organs or tissues because the metal oxides, due to their superparamagnetic properties, exert profound effects on the hydrogen nuclei responsible for the MR image. In addition, the dispersoids and fluids are quite stable and, in the case of the fluids, can even be subjected to autoclaving without impairing their utility. Furthermore, the materials are biodegradable and, in the case of iron oxide compounds, can eventually be incorporated into the subject's hemoglobin, making them useful in treating anemia. Thus, the materials are well-suited for in vivo use.
Inventor(s): Groman; Ernest V. (Brookline, MA), Josephson; Lee (Arlington, MA), Lewis; Jerome M. (Newton, MA)
Assignee: Advanced Magnetics, Inc. (Cambridge, MA)
Application Number:07/863,360
Patent Claim Types:
see list of patent claims
Formulation; Compound;
Patent landscape, scope, and claims:

Understanding the Scope and Claims of United States Patent 5,219,554

To delve into the details of the scope and claims of a specific patent, such as United States Patent 5,219,554, it is essential to analyze several key aspects, including the patent's claims, the technological context, and the broader patent landscape.

Patent Claims Analysis

Claim Structure

Patent claims are the heart of any patent, defining the scope of the invention and what is protected. For U.S. Patent 5,219,554, the claims would typically be categorized into independent and dependent claims. Independent claims stand alone and define the invention, while dependent claims refer back to and further limit the independent claims[3].

Claim Scope

The scope of the claims is crucial in determining the patent's breadth and what constitutes infringement. Narrower claims are generally easier to defend but offer less protection, while broader claims provide more extensive protection but are more challenging to enforce and may face more scrutiny during the examination process[3].

Technological Context

Invention Overview

Understanding the technological context in which the patent was granted is vital. This involves identifying the problem the invention solves, the state of the art at the time of filing, and how the invention improves upon existing technologies.

Prior Art and Novelty

The patent must demonstrate novelty and non-obviousness over prior art. This means the invention must be new and not obvious to a person of ordinary skill in the relevant field. The patent office would have conducted a thorough search of prior art to ensure these criteria are met[4].

Patent Eligibility

Subject Matter Eligibility

The 2024 USPTO guidance update on AI patents provides insights into how subject matter eligibility is determined. For any patent, including U.S. Patent 5,219,554, the claims must integrate a judicial exception into a practical application to be considered patent-eligible. This involves assessing whether the additional elements in the claim impose meaningful limits on the exception, transforming the claim into patent-eligible subject matter[1].

Practical Applications

Highlighting the real-world applications of the claimed method or system is crucial. Demonstrating how the abstract idea is applied in a way that provides concrete benefits or solves specific problems in the relevant field is essential for patent eligibility[1].

Patent Landscape

Search and Analysis Tools

To understand the broader patent landscape, tools like the USPTO's Patent Public Search, Global Dossier, and Common Citation Document (CCD) are invaluable. These tools allow for comprehensive searches of prior art, related applications, and citation data, helping to contextualize the patent within its field[4].

International Considerations

Patents are often part of a global family of applications. Using resources like the European Patent Office's esp@cenet, the Japan Patent Office, and the World Intellectual Property Organization's PATENTSCOPE can provide a global perspective on the patent's scope and potential international protections[4].

Patent Scope Metrics

Independent Claim Length and Count

Research has shown that metrics such as independent claim length and count can be useful in measuring patent scope. Narrower claims, as indicated by shorter lengths and fewer counts, are often associated with a higher probability of grant and a shorter examination process[3].

Maintenance and Enforcement

Patent Maintenance Payments

The cost of maintaining a patent, including maintenance payments, can be a significant factor. Patents with narrower claims may have lower maintenance costs and are less likely to face challenges during the maintenance period[3].

Litigation and Licensing

The scope of the patent claims also affects litigation and licensing strategies. Broader claims may increase the risk of litigation but can also provide stronger bargaining power in licensing negotiations[3].

Case Law and Regulatory Updates

Incorporation of Recent Case Law

The 2024 USPTO guidance update emphasizes the importance of incorporating recent case law in evaluating patent eligibility. This ensures that the patent claims are aligned with current legal standards and reduces the risk of section 101 rejections[1].

Regulatory Environment

Understanding the regulatory environment, including updates like the 2024 USPTO guidance, is crucial for navigating the patent landscape. These updates can significantly impact how patent claims are drafted and evaluated[1].

Expert Insights and Stakeholder Engagement

Consultative Groups and Public Comments

Engagement with consultative groups and public comments, as seen in the study for a small claims patent court, highlights the importance of stakeholder input in shaping patent policies and practices. This ensures that the patent system remains responsive to the needs of innovators and practitioners[2].

Key Takeaways

  • Claim Structure and Scope: Understanding the structure and scope of patent claims is essential for determining the invention's protection and potential infringement.
  • Technological Context: The invention must be understood within its technological context, including prior art and novelty.
  • Patent Eligibility: Claims must integrate judicial exceptions into practical applications to be patent-eligible.
  • Patent Landscape: Using various search tools and international resources helps in contextualizing the patent within its field.
  • Metrics and Maintenance: Metrics like claim length and count, along with maintenance costs, are important for managing the patent.
  • Case Law and Regulation: Incorporating recent case law and regulatory updates is crucial for aligning patent claims with current legal standards.

FAQs

1. What is the importance of claim structure in a patent?

The claim structure defines the scope of the invention and what is protected. Independent claims stand alone, while dependent claims further limit the independent claims.

2. How does the 2024 USPTO guidance update impact AI-related patents?

The update clarifies that the method of invention development, including AI, does not impact subject matter eligibility. Instead, it focuses on whether the claimed invention integrates a judicial exception into a practical application.

3. What tools are available for searching prior art and related patent applications?

Tools like the USPTO's Patent Public Search, Global Dossier, and Common Citation Document (CCD) are available for comprehensive searches of prior art and related applications.

4. How do metrics like claim length and count affect patent scope?

Narrower claims, indicated by shorter lengths and fewer counts, are often associated with a higher probability of grant and a shorter examination process.

5. Why is stakeholder engagement important in patent policy?

Stakeholder engagement ensures that the patent system remains responsive to the needs of innovators and practitioners, helping to shape policies and practices that are effective and fair.

Cited Sources:

  1. Understanding the 2024 USPTO Guidance Update on AI Patent - Mintz.
  2. U.S. Patent Small Claims Court - ACUS.
  3. Patent Claims and Patent Scope - SSRN.
  4. Search for patents - USPTO - USPTO.

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 5,219,554

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.